-
Views
-
Cite
Cite
Uri Elkayam, Bromocriptine in the treatment of peripartum cardiomyopathy: is it ready for prime time?, European Heart Journal, Volume 46, Issue 11, 14 March 2025, Pages 1028–1030, https://doi.org/10.1093/eurheartj/ehae875
- Share Icon Share

Graphical Abstract
Peripartum cardiomyopathy (PPCM): facts and challenges.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights)
You do not currently have access to this article.